Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Artificial Intelligence (AI) In Respiratory Diseases Market Size Shifted, And What Is the Outlook Through 2034?
The market size of artificial intelligence (AI) applied to respiratory diseases has been on a consistent rise over the past few years. The value of the market is predicted to increase from $7.66 billion in 2024 to $7.98 billion in 2025, recording a compound annual growth rate (CAGR) of 4.2%. This growth trend during the historical period is primarily due to a rise in government regulations, enhanced environmental awareness, a surge in the elderly population, a shift towards patient-centered healthcare models, and an escalation in the development of healthcare infrastructure.
The market size for artificial intelligence (AI) in respiratory diseases is predicted to experience consistent growth in the coming years, reaching a value of$9.7 billion in 2029 with a compound annual growth rate (CAGR) of 5.0%. This predicted growth throughout the forecast period can be linked to a rise in respiratory disease prevalence, an increased demand for early detection and diagnosis, escalating environmental pollution, growing healthcare expenses, and ongoing research and development efforts. Notable trends expected during the forecast period comprise technological evolution, drug discovery and creation, individualized treatment methodologies, the use of telemedicine and remote patient monitoring methodologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
Which Primay Drivers Are Accelerating Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?
The escalating issue of environmental pollution is anticipated to fuel the expansion of artificial intelligence (AI) in the respiratory disease market. Environmental pollution is typically characterized by the accumulation of substances or energy forms in the environment at a pace quicker than they can be safely dispersed or stored. The application of AI in respiratory diseases can drastically minimize the repercussions of environmental pollution on respiratory health. This is done by providing real-time monitoring, personalized risk evaluations, informed decision making, and pioneering solutions for individuals and communities alike. For example, data from the US Energy Information Administration, a government agency based in the US, indicated that in June 2024, the level of CO2 emissions in 2021 was at 35.72 billion metric tons, jumping to 38.50 billion metric tons in 2022. Consequently, the rising environmental pollution is spurring the development of artificial intelligence (AI) in the respiratory disease market.
Which Primary Segments of the Artificial Intelligence (AI) In Respiratory Diseases Market Are Driving Growth and Industry Transformations?
The artificial intelligence (AI) in respiratory diseasesmarket covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease; Interstitial Lung Disease; Pulmonary Infection
3) By End Use: Hospital; Diagnostic Centers; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging; Thoracic Imaging; Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT); Low-Dose CT; Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking; Medication Adherence Monitoring; Quality Of Life Assessments
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?# Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Artificial Intelligence (AI) In Respiratory Diseases Industry Dynamics?
Leading corporations in the artificial intelligence (AI) sector of the respiratory diseases market are advancing in the development of specialized products like the N-Tidal devices, used for monitoring tidal breathing in patients. With the help of the n-Tidal device, the volume of air exchanged in regular breathing can be measured, offering essential insights into the functioning of the lungs. For example, TidalSense, a UK-based company specializing in respiratory technology, released an AI-based technology, N-Tidal, in August 2023. This technology incorporates N-Tidal’s CO2 sensor data into an AI platform for the diagnosis and management of chronic obstructive pulmonary disease (COPD). This strategic combination is aimed at enhancing the monitoring of lung function changes, thereby improving the diagnosis and handling of this respiratory disease. Clinical trials indicate high accuracy levels of this technology, which is set to revolutionize the method of diagnosing respiratory diseases. This breakthrough marks substantial progress in utilizing AI for the evaluation of respiratory diseases, presenting a remarkably more comfortable and efficient alternative to existing diagnostic procedures.
View the full report here:
What Parameters Are Used to Define the Artificial Intelligence (AI) In Respiratory Diseases Market?
Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model